Galmed Pharmaceuticals

-$0.06 (-2.14%) Today
+$0.04 (+1.46%) As of 8:52 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.

About GLMD

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.

CEO
Allen Baharaff
Employees
24
Headquarters
Tel Aviv, Tel Aviv
Founded
2000

GLMD Key Statistics

Market Cap
87.63M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
827.60K
High Today
$2.81
Low Today
$2.68
Open Price
$2.81
Volume
278.43K
52 Week High
$6.25
52 Week Low
$2.15

GLMD Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.38 per share
Actual
Available Aug 5, Pre-Market
Preview Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure